Jamiley Fisher

Jamiley Fisher supports the procurement mission of W40M MRCO Pacific under the Department of the Army, managing critical acquisitions that sustain medical readiness for U.S. forces across the Indo-Pacific region. Responsible for executing contracts for advanced biomedical infrastructure, Fisher specializes in securing in-vitro diagnostic systems, electromedical equipment, surgical instruments, and clinical laboratory services essential to military treatment facilities. Their work ensures operational continuity of high-acuity medical capabilities in deployed environments, aligning acquisitions with DoD standards for reliability, sterilization, and field durability. Fisher handles complex, technical procurements requiring stringent compliance with federal medical device regulations and defense logistics protocols. Fisher maintains long-standing relationships with leading biomedical and diagnostics providers, including Roche Diagnostics Corporation, BioFire Defense LLC, Siemens Healthcare Diagnostics Inc., Jupiter Logix Inc., and Island Neuro Inc. These partnerships reflect a preference for vendors with proven capabilities in military-grade diagnostic platforms, rapid pathogen detection systems, and integrated clinical data interfaces. The contracting approach emphasizes performance-based requirements, lifecycle support, and secure data interoperability, fostering collaborative vendor engagement to meet expeditionary medical needs under austere conditions. Fisher’s procurement portfolio reflects a strong emphasis on open competition, with 71.4% of awards issued without set-aside restrictions. The remaining 28.6% are structured as Total Small Business Set-Asides under FAR 19.5, demonstrating a deliberate commitment to expanding small business participation in high-technology medical procurement. While no specific socioeconomic categories like 8(a) or SDVOSB dominate, the consistent use of small business set-asides signals a strategic effort to diversify the supplier base and leverage innovation from agile, specialized firms. The primary NAICS focus areas include 339112 (Surgical and Medical Instrument Manufacturing) and 339114 (Dental Equipment and Supplies Manufacturing), alongside 621511 (Medical Laboratories) and 541380 (Testing Laboratories and Services). Fisher’s expertise centers on procuring precision surgical tools, automated lab analyzers, point-of-care diagnostics, and integrated clinical support systems, requiring deep technical understanding of medical device classification, ISO 13485 compliance, and biocompatibility standards.